The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States
W Weng, Y Tian, SX Kong, R Ganguly… - Endocrinology …, 2019 - Wiley Online Library
Objectives The purpose of this study was to assess atherosclerotic cardiovascular disease
(ASCVD) prevalence, antidiabetes medication usage and physician specialty encounters …
(ASCVD) prevalence, antidiabetes medication usage and physician specialty encounters …
The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States.
W Weng, Y Tian, SX Kong, R Ganguly… - Endocrinology …, 2019 - europepmc.org
Objectives The purpose of this study was to assess atherosclerotic cardiovascular disease
(ASCVD) prevalence, antidiabetes medication usage and physician specialty encounters …
(ASCVD) prevalence, antidiabetes medication usage and physician specialty encounters …
The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States
W Weng, Y Tian, SX Kong, R Ganguly… - Endocrinology …, 2019 - search.proquest.com
Objectives The purpose of this study was to assess atherosclerotic cardiovascular disease
(ASCVD) prevalence, antidiabetes medication usage and physician specialty encounters …
(ASCVD) prevalence, antidiabetes medication usage and physician specialty encounters …
[HTML][HTML] The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States
W Weng, Y Tian, SX Kong, R Ganguly… - Endocrinology …, 2019 - ncbi.nlm.nih.gov
Objectives The purpose of this study was to assess atherosclerotic cardiovascular disease
(ASCVD) prevalence, antidiabetes medication usage and physician specialty encounters …
(ASCVD) prevalence, antidiabetes medication usage and physician specialty encounters …
The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States
W Weng, Y Tian, SX Kong… - Endocrinology …, 2019 - pubmed.ncbi.nlm.nih.gov
Objectives The purpose of this study was to assess atherosclerotic cardiovascular disease
(ASCVD) prevalence, antidiabetes medication usage and physician specialty encounters …
(ASCVD) prevalence, antidiabetes medication usage and physician specialty encounters …
The prevalence of cardiovascular disease and antidiabetes treatment characteristics among a large type 2 diabetes population in the United States.
W Weng, Y Tian, SX Kong, R Ganguly… - Endocrinology …, 2019 - europepmc.org
Objectives The purpose of this study was to assess atherosclerotic cardiovascular disease
(ASCVD) prevalence, antidiabetes medication usage and physician specialty encounters …
(ASCVD) prevalence, antidiabetes medication usage and physician specialty encounters …